Content about Drug Price Competition and Patent Term Restoration Act

September 1, 2011
FTC: Authorized generics reduce overall drug prices

Branded drugs sold under their generic names at a reduced price can reduce retail and wholesale drug prices, according to a new report by the Federal Trade Commission.

June 21, 2011
Watson seeks to commercialize generic Avodart

Watson subsidiary Watson Labs is seeking approval for a drug designed to treat symptomatic benign prostatic hyperplasia in men with an enlarged prostate.

May 20, 2011
Sandoz looks to market generic Vyvanse

Sandoz is looking to market a generic version of a Shire drug for treating attention deficit hyperactivity disorder.

April 21, 2011
Watson confirms Welchol patent challenge

Watson Pharmaceuticals is hoping to become the first company to market a generic treatment for cholesterol.

April 8, 2011
Watson faces patent challenge over generic Vigamox

Watson announced that its subsidiary is seeking approval to market a generic version of a bacterial conjunctivitis treatment.

February 25, 2011
Watson seeks regulatory approval for generic Adderall XR

Watson Labs is hoping to be the first to market a generic version of a popular drug for attention deficit hyperactivity disorder.

January 31, 2011
Mylan looks to market generic Lidoderm

Mylan has announced its intention to market a version of a painkiller made by Endo Pharmaceuticals and partner company Teikoku Seiyaku ahead of patent expiration.

January 28, 2011
Mylan's generic Sular gets FDA OK

The Food and Drug Administration has approved a generic hypertension treatment made by Mylan.

January 26, 2011
Watson seeks FDA approval for generic Welchol

Watson Pharmaceuticals is seeking regulatory approval for a generic drug for high cholesterol.

January 4, 2011
Par begins shipping two strengths of generic Lotrel

Par Pharmaceutical has started shipping a generic version of a hypertension drug, the company said Monday.

January 4, 2011
Par launches generic Rhythmol SR

Generic drug maker Par Pharmaceutical has begun shipping its version of a treatment for heart rhythm problems, the company said Monday.

December 15, 2010
Watson confirms patent challenge over generic Exalgo

Drug maker Watson Pharmaceuticals said it has filed a regulatory approval application for a generic painkiller, challenging the patent that covers the branded version.

November 29, 2010
Impax challenges Abbott's Simcor patent

Generic drug maker Impax Labs is challenging the patent covering a drug used to treat high cholesterol, the company said Friday.

November 15, 2010
Labopharm reviewing notification of Actavis' approval application for generic Oletpro

Generic drug maker Actavis has filed for approval of a generic version of an antidepressant...

October 4, 2010
Report: Ranbaxy to market generic Aricept

Ranbaxy has won the right to sell a generic version of an Alzheimer’s disease drug...

October 4, 2010
Watson confirms patent challenge for generic Azilect

Generic drug maker Watson Pharmaceuticals is seeking approval for a generic treatment for Parkinson’s disease,...

September 9, 2010
Sorry, FTC: 'Pay-for-delay' isn't going away

This week’s decision by the U.S. Second Circuit Court of Appeals could make political efforts...

September 6, 2010
Watson confirms patent challenge for generic Combigan

Generic drug maker Watson Pharmaceuticals has applied for Food and Drug Administration approval for a...

August 11, 2010
GPhA: Banning patent settlements will cost money, not save it

The main lobbying group for the generic drug industry said federal authorities erred in projecting...

June 13, 2010
Gilead patent for Ranexa challenged by Lupin

Indian generic drug maker Lupin is challenging a Gilead Sciences patent for a drug that...

June 10, 2010
Sandoz opens new generics development site

Sandoz has opened what it calls a key site for the development of generic drugs...

May 25, 2010
Watson confirms patent challenge for generic Renvela

Generic drug maker Watson Pharmaceuticals is challenging the patent on a drug for treating kidney...

May 19, 2010
Sandoz to market generic Skelaxin

Sandoz has launched a generic version of a muscle relaxant, the generics arm of Swiss...

May 5, 2010
Watson seeks approval for generic Evista

Watson Pharmaceuticals is challenging the patent covering a drug for postmenopausal women, the generic drug...

May 2, 2010
Watson confirms patent challenge for Trilipix generic

Drug maker Abbott has sued a Watson Pharmaceuticals subsidiary over its attempt to market a...

© 2013 Drug Store News. All Rights Reserved.